Mesoblast Company Update - Webcast and Forward Thoughts, page-222

He at the very minimum has failed to declare a potential and well know conflict of interest. Its a minefield. Now I understand a bit more about the confident "its a process" tact by management. Absolutely no way others on the ODAC Committee didn't know - they all read the journals in their area of expertise. I cannot understand why he would not declare this. It was always going to surface.

SI/FG can never call it out publicly, but they surely must know this and presumably will cite it in their type A request. To suggest imporprietary within the FDA is something onlookers can do with ease, but it would be detrimental to MSB's cause to do so. They will have to tread cautiously. As said, we don't. Get it out on social media. Even if the guy was utterly genuine, he absolutely should have declared this. He has a patent in a competing therapeautic approach and refers potential GvHD application in an academic journal. He absolutely should have declared this. Minimum.